It struck me that the challenge area we are dealing with is about people not taking their meds in the way that the doctor intented them to.
It struck me that the challenge area we are dealing with is about people not taking their meds in the way that the doctor intented them to. It is evident that this is the result of not only the patient being at fault since everything around the patient is not fully functioning in most of the cases.
Based on this insight, I have come to the conclusion that we are better off using the term 'medication adherence' rather than 'patient compliance' -- the latter implies disobedient patients and leads us to focus the energy on more and better information to patients only. We might be barking up the wrong tree...
blog comments powered by DisqusAndrew Tolve investigates the value of the Internet as a pharma marketing research medium
Often criticised for not properly adopting new web technologies, pharma proves it knows a thing or two about the corporate website.
Jan Stojaspal explores the role of value-based pricing in gaining market access
Alex Gochtovtt, principal with Cognizant’s enterprise analytics practice, discusses pharma’s social media opportunities and the importance of data analytics
An interview with Serkan Erkovan of Boehringer Ingelheim.
Ashok Bhaseen, Vice President of Sales & Marketing at Pediapharm reveals how his company establishes trust when engaging KOLs